In safe hands

20+ years in Pharma 

Genzyme, AstraZeneca, and Sanofi · Global Lead, Governance & Compliance in Ethics & Business Integrity · Founder of Patient Support Program Industry Network · Leader in Managed Access Industry Forum · Co-author, Therapeutic Innovation & Regulatory Science, 2025 · Global regulatory expertise · Rare disease & oncology

Pharmaceutical Consulting - Early Access to Medicines

Pathways providing patients with access to medicines

With my background across the various pathways providing patients with access to medicines, I collaborate with pharma and biotech organisations offering expanded or managed access programmes that require senior strategic knowledge and expertise.

Whether you're building infrastructure for the first time, navigating a complex regulatory environment, or preparing to take a programme to the next level internally.

You need someone with deep operational knowledge of the regulatory landscape who translates that into practical, implementable global policy and governance.

The goal is always for your organisation to own this. I work alongside your team to build the internal capability and infrastructure to sustain your programme independently whether that's through training, reviewing and strengthening your operating procedures, or identifying what you don't yet know you need.

In 2025, I co-authored a peer-reviewed publication in compassionate use and expanded access (Therapeutic Innovation & Regulatory Science, 2026).

→ Work with me

Read the publication here →  Industry Perspective on Compassionate Use in Europe:

Working with my colleagues

“Working with Annie was a deeply meaningful experience. She has a naturally gentle, calming, and warm presence that immediately puts you at ease. At the same time, she is wonderfully full of sparkle — bringing a lightness and energy that makes every interaction feel alive, engaging, and genuinely fun.”

—  Marine E, Former Colleague, Sanofi

“Annie has a rare gift: she makes difficult things feel easier by bringing such calm, structure and genuine care to the work that you never feel alone in facing them. Her way of working gives you confidence, while her warmth and attentiveness make every interaction feel genuinely collaborative. What stood out most was how appreciated and at ease she made me feel throughout our collaboration.

— Ruth F, Former Colleague, Sanofi

“Working with Annie was consistently a positive and grounding experience. From the start, she brought a warm, approachable presence that made collaboration feel natural and supportive. She has a unique ability to remain level-headed, even in high-pressure or challenging situations, and often served as a thoughtful sounding board that helped make complex or urgent issues feel much more manageable.”

— Derek V, Former Colleague, Sanofi

Who is this for?

Any pharma or biotech organisation with an expanded or managed access programme that lacks senior strategic resource — whether you’re building infrastructure for the first time, navigating a complex regulatory environment, or preparing to take a programme to the next level internally.

You have the team - you need someone who brings both the strategic depth and the genuine passion to do this well for the patients who are waiting.

→ Tell me about your industry challenge
Expanded access to medicine
Expanded access to medicine

My approach…

  • Expert input at the decision-making stage. This is for organisations with internal capability that need a senior external perspective — someone who knows the global regulatory landscape in depth, understands how country-level variation affects implementation, and can help you think clearly about what your programme needs, identifying and minimising risk through implementable guardrails

  • Designing and building the internal infrastructure that makes early and managed access and compassionate use programmes equitable and sustainable. Practical policies grounded in how these pathways actually operate across different regulatory environments

  • Helping programme leads translate complex expanded and managed access strategy into the language of senior internal decision-makers — those with budget authority and sign-off power. I help you build the internal case, navigate cross-functional governance, and secure the leadership alignment your programme needs to move forward.

  • Early access doesn't sit in one function or one organisation. Internally it spans medical, regulatory, legal, privacy, supply, pharmacovigilance, and policy. Externally it touches patients, physicians, and advocacy groups whose expectations need honest, careful management. I help organisations navigate that full complexity — from the inside out.

Let’s work together

If you're interested in working with me, complete the form with a few details about your project. I will review your message and get back to you within 48 hours.